Signaling pathways
-
BA6566 GSK-7975ASummary: Highly potent orally active channel inhibitor. -
BA6567 N106Summary: N106 is the first activator of the sarcoplasmic reticulum calcium ATPase SUMOylation.
-
BA6568 BupivacaineSummary: Bupivacaine is a receptor inhibitor. -
BA6569 SG-094Summary: SG-094 is a potent inhibitor with antiproliferative activity.
-
BA6570 HC-056456Summary: HC-056456 is a potent but incompletely selective channel blocker.
-
BA6571 DehydronitrosonisoldipineSummary: Dehydronitrosonisoldipine, a derivative of nisoldipine, is a reversible and cell-permeable inhibitor.
-
BA6572 TTA-A2Summary: TTA-A2 is a potent, selective and orally active T-type voltage-gated calcium channel antagonist that reduces pregnane X receptor (PXR) activation.
-
BA6573 AzumoleneSummary: Azumolene (EU4093 free base), an analog of Dantrolene, is a muscle relaxant.
-
BA6574 DiltiazemSummary: Diltiazem is an oral L-type calcium channel blocker. -
BA6575 BX430Summary: BX430 is a potent and selective non-competitive human receptor channel variant antagonist.